Show source-provided references
1. Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: Estimates from the 2019 Global Burden of Disease Study
10.1186/s13075-021-02705-6 ↗3. Long-term outcomes of total hip arthroplasty in patients younger than 55 years: A systematic review of the contemporary literature
10.1503/cjs.013118 ↗4. Current methods of preventing aseptic loosening and improving osseointegration of titanium implants in cementless total hip arthroplasty: A review
10.1177/0300060517732697 ↗6. Tibolone, alendronate, and simvastatin enhance implant osseointegration in a preclinical in vivo model
10.1111/clr.13602 ↗8. Selective Use of Low Dose Tranexamic Acid in Orthopedic Surgery
9. Biochemical markers of bone remodeling—Review
10. Partial weightbearing is not necessary after cementless total hip arthroplasty: A two-year prospective randomized study on 100 patients
10.1007/s00264-010-1089-2 ↗13. Reiner, T., Sonntag, R., Kretzer, J.P., Clarius, M., Jakubowitz, E., Weiss, S., Ewerbeck, V., Merle, C., Moradi, B., and Kinkel, S. (2020). The Migration Pattern of a Cementless Hydroxyapatite-Coated Titanium Stem under Immediate Full Weight-Bearing-A Randomized Controlled Trial Using Model-Based RSA. J. Clin. Med., 9.
10.3390/jcm9072077 ↗14. Efficiency of Zoledronic Acid in Inhibiting Accelerated Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty in Osteoporotic Patients: A Prospective, Cohort Study
10.1111/os.12513 ↗15. Periprosthetic bone loss after insertion of an uncemented, customized femoral stem and an uncemented anatomical stem. A randomized DEXA study with a 5-year follow-up
10.3109/17453674.2011.588860 ↗16. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty—A 5-year follow-up of 16 patients
10.1177/145749691009900108 ↗18. A comparison of the effects of alendronate and alfacalcidol on bone mineral density around the femoral implant and in the lumbar spine after total hip arthroplasty
10.2106/JBJS.I.01714 ↗19. The effect of simvastatin on periprosthetic bone mineral density in the hypercholesterolaemic patients after total hip arthroplasty
10.1007/s00264-017-3551-x ↗21. A 2003 update of bone physiology and Wolff’s Law for clinicians